<https://rdf.molmedb.upol.cz/reference/ref4213> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM494630>,
		<https://identifiers.org/molmedb/MM494631>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2019.126749"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/ontology/bibo/pmid> "31672259"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method30>,
		<https://rdf.molmedb.upol.cz/interaction/membrane18>;
	<http://purl.org/dc/terms/bibliographicCitation> "Mizojiri R, Asano M, Sasaki M, Satoh Y, Yamamoto Y, Sumi H, Maezaki H.: The identification and pharmacological evaluation of potent, selective and orally available ACC1 inhibitor. Bioorg Med Chem Lett, Volume 29 (23), 2019"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://rdf.molmedb.upol.cz/interaction/int1020408> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4213> .
<https://rdf.molmedb.upol.cz/interaction/int1020409> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4213> .
